deltatrials
Unknown NA INTERVENTIONAL 1-arm NCT03302884

Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma (CIDOC)

Sponsor: AstraZeneca

Conditions Ovarian Carcinoma
Interventions biological sampling
Updated 9 times since 2017 Last updated: Sep 25, 2019 Started: Oct 10, 2018 Primary completion: Oct 30, 2023 Completion: Oct 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Ovarian Carcinoma, this trial is ongoing. The trial is conducted by AstraZeneca and has accumulated 9 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Oct 2017 – ~Nov 2017 · 31 days · monthly snapshotNot Yet Recruiting~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshotNot Yet Recruiting~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotRecruiting~Jan 2021 – ~Dec 2023 · 35 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  4. Dec 2023 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  5. Jan 2021 — Dec 2023 [monthly]

    Recruiting NA

▶ Show 4 earlier versions

  1. Oct 2019 — Jan 2021 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  2. Jun 2018 — Oct 2019 [monthly]

    Not Yet Recruiting NA

  3. Nov 2017 — Jun 2018 [monthly]

    Not Yet Recruiting NA

  4. Oct 2017 — Nov 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • Institut Paoli-Calmettes
Data source: Institut Paoli-Calmettes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations